Saxenda liraglutide injection, solution, DailyMed (2025) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) First generic GLP-1 indicated for weight loss, Teva Pharmaceuticals Investor Relations (2025) Liraglutide injection, solution, DailyMed (2025) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, Food and Drug Administration (2024) Bioequivalence and interchangeability of generic medications, Merck Manual Consumer Version (2025) Liraglutide injection, DailyMed (2025) Medicare coverage of GLP-1 drugs, Library of Congress (2024) FDA drug shortages, Food and Drug Administration (2025) Compounding when drugs are on FDAs Drug Shortages List, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Wendy Townsend spoke to Elora about this new For more information visit bellemedical.com Follow Fresh Living on social media, subscribe to our newsletter, and check out our podcast for more
Your refrigerator thermostat fails overnight
Some early reports suggest that reducing dose frequency may help certain patients maintain weight loss, but experts also caution that microdosing itself is loosely defined and not supported by robust long-term data
However, the rise of compounded GLP-1s comes with serious safety and regulatory concerns